Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Journal of Cancer Research and Clinical Oncology|January 1, 1983
Phase-II clinical trial of 4'-epi-doxorubicin in metastatic solid tumorsK Kolarić, V Potrebica, J CervekAnti-Cancer Drugs|April 6, 2001
Selection of candidates for oral etoposide salvage chemotherapy in heavily pretreated breast cancer patientsM Jagodic, T Cufer, B Zakotnik, et al.Tumori|February 29, 1992
Combination of 5-fluorouracil, imidazole carboxamide, BCNU and prednisolone (FIB-P) as a salvage chemotherapy in heavily pretreated breast cancer patientsT Cufer, K Kolaric, J Cervek, et al.Cancer Letters|December 20, 1996
Clinical evaluation of potential usefulness of CEA, CA 15-3, and MCA in follow-up of breast cancer patientsB Jezersek, J Cervek, Z Rudolf, et al.Tumori|September 1, 1996
First-line chemotherapy with cisplatin, methotrexate and vinblastine in metastatic bladder cancerB Pajk, T Cufer, J Cervek, et al.Cancer Chemotherapy and Pharmacology|January 1, 1984
CAP (cyclophosphamide, adriamycin, platinum) vs CMFVP (cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisolone) combination chemotherapy in untreated metastatic breast cancer. A preliminary report of a controlled clinical studyK Kolarić, A Roth, D Vukas, et al.Journal of Interferon Research|August 1, 1987
Intrapleural application of human leukocyte interferon (HLI) in breast cancer patients with ipsilateral pleural carcinomatosisB Jereb, M Us-Krasovec, J Cervek, et al.International Journal of Radiation Oncology, Biology, Physics|April 2, 1993
Sequential transurethral surgery, multiple drug chemotherapy and radiation therapy for invasive bladder carcinoma: initial reportJ Cervek, T Cufer, B Kragelj, et al.Tumori|April 30, 1985
Cyclophosphamide, adriamycin and platinum (CAP) combination chemotherapy, a new effective approach in the treatment of disseminated breast cancer. Preliminary reportK Kolarić, D Vukas, A Roth, et al.International Journal of Radiation Oncology, Biology, Physics|February 8, 2000
Prognostic factors in invasive bladder carcinoma treated by combined modality protocol (organ-sparing approach)T Matos, T Cufer, J Cervek, et al.Pageof 2